Literature DB >> 25939544

Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.

Chen Wei1, Wen-Ying Deng, Ning Li, Wei Shen, Chi Zhang, Jia-Yu Liu, Su-Xia Luo.   

Abstract

BACKGROUND: The prognostic value of metastatic lymph node ratio (LNR) is still controversial in esophageal cancer. AIM: This study aimed to compare the impact of AJCC N staging system (pN) and LNR on the prediction of long-term survival of patients with esophageal carcinoma.
METHODS: A total of 496 patients were retrospectively analyzed who underwent esophageal resection at Henan Tumor Hospital from January 2006 to December 2010. The Kaplan-Meier method and log-rank test were used to estimate survival curves. Univariate and multivariate analyses were performed to compare prognostic factors for long-term survival. The difference between pN and LNR with overall survival (OS) was compared by receiver operating characteristic (ROC) curve and area under the curve (AUC).
RESULTS: The 1-, 3-, 5-year overall survival rates of 496 patients were 73.6, 47.1 and 34.2 %, respectively. Univariate analyses showed that diseased region, tumor length, depth of tumor invasion, pN and LNR affected the prognosis, and multivariate analyses demonstrated that depth of tumor invasion, pN and LNR were independent risk factors. Among the three significant variables verified by multivariate analyses, LNR was the best for inadequately staged patients (<12 examined LNs). ROC analyses showed that compared with pN (AUC = 0.579, p = 0.037), LNR (AUC = 0.680, p = 0.002) had better predictive value (z = 2.275, p = 0.029).
CONCLUSIONS: LNR has greater prognostic value than pN for esophageal squamous cell carcinoma, especially for patients with <12 LNs removed.

Entities:  

Mesh:

Year:  2015        PMID: 25939544     DOI: 10.1007/s10620-015-3681-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.

Authors:  Hao-Xian Yang; Ying Xu; Jian-Hua Fu; Jun-Ye Wang; Peng Lin; Tie-Hua Rong
Journal:  Ann Surg Oncol       Date:  2010-02-10       Impact factor: 5.344

2.  The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Authors:  Qi-Rong Xu; Xue-Peng Zhuge; He-Lin Zhang; Yu-Min Ping; Long-Qi Chen
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

3.  Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.

Authors:  Adam C Berger; Elin R Sigurdson; Thomas LeVoyer; Alexandra Hanlon; Robert J Mayer; John S Macdonald; Paul J Catalano; Daniel G Haller
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

4.  An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus.

Authors:  Bas P L Wijnhoven; Khe T C Tran; Adrian Esterman; David I Watson; Hugo W Tilanus
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

5.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

6.  New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2010-01-23       Impact factor: 5.344

7.  Prognostic significance of lymph node metastases and ratio in esophageal cancer.

Authors:  Matthew Wilson; Ernest L Rosato; Karen A Chojnacki; Inna Chervoneva; John C Kairys; Herbert E Cohn; Francis E Rosato; Adam C Berger
Journal:  J Surg Res       Date:  2007-08-28       Impact factor: 2.192

8.  Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.

Authors:  Y P Liu; L Ma; S J Wang; Y N Chen; G X Wu; M Han; X L Wang
Journal:  Eur J Surg Oncol       Date:  2009-10-25       Impact factor: 4.424

9.  The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer.

Authors:  Wen-Hu Hsu; Po-Kuei Hsu; Chih-Cheng Hsieh; Chien-Sheng Huang; Yu-Chung Wu
Journal:  J Gastrointest Surg       Date:  2009-08-12       Impact factor: 3.452

10.  Ratios of involved nodes in early breast cancer.

Authors:  Vincent Vinh-Hung; Claire Verschraegen; Donald I Promish; Gábor Cserni; Jan Van de Steene; Patricia Tai; Georges Vlastos; Mia Voordeckers; Guy Storme; Melanie Royce
Journal:  Breast Cancer Res       Date:  2004-10-06       Impact factor: 6.466

View more
  16 in total

1.  Impact of Lymph Node Sampling in Stage II and III Epithelial Ovarian Cancer Patients with Clinically Negative Lymph Nodes.

Authors:  Mohamed Ibrahim Fahim; Abdelmaksoud Mohamed Ali; Rasha Mahmoud Allam
Journal:  Indian J Surg Oncol       Date:  2019-12-02

Review 2.  Strategies of nodal staging of the TNM system for esophageal cancer.

Authors:  Wen-Ping Wang; Song-Lin He; Yu-Shang Yang; Long-Qi Chen
Journal:  Ann Transl Med       Date:  2018-02

3.  Identification of differentially expressed proteins in the locoregional recurrent esophageal squamous cell carcinoma by quantitative proteomics.

Authors:  Wei-Wei Yu; Xiao-Long Fu; Xu-Wei Cai; Meng-Hong Sun; Yan-Mei Guo
Journal:  J Gastrointest Oncol       Date:  2021-06

4.  Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.

Authors:  Juan Zhou; Zhen-Yu He; Feng-Yan Li; Jia-Yuan Sun; Huan-Xin Lin; San-Gang Wu; Qiong-Hua Chen
Journal:  Oncotarget       Date:  2016-02-16

5.  Lymph node ratio may predict the benefit of postoperative radiotherapy in node-positive cervical cancer.

Authors:  Juan Zhou; Qiong-Hua Chen; San-Gang Wu; Zhen-Yu He; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Ke-Li You
Journal:  Oncotarget       Date:  2016-05-17

6.  Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.

Authors:  Yuming Zhao; Shengyi Zhong; Zhenhua Li; Xiaofeng Zhu; Feima Wu; Yanxing Li
Journal:  Oncotarget       Date:  2017-07-15

7.  The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.

Authors:  Vignesh Raman; Oliver K Jawitz; Norma E Farrow; Soraya L Voigt; Kristen E Rhodin; Chi-Fu J Yang; Megan C Turner; Thomas A D'Amico; David H Harpole; Betty C Tong
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 13.787

8.  Prognostic value of lymph node ratio in patients with small-cell carcinoma of the cervix based on data from a large national registry.

Authors:  Juan Zhou; Jia-Yuan Sun; Shan-Yu Chen; Feng-Yan Li; Huan-Xin Lin; San-Gang Wu; Zhen-Yu He
Journal:  Onco Targets Ther       Date:  2015-12-23       Impact factor: 4.147

9.  Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.

Authors:  Hongdian Zhang; Huagang Liang; Yongyin Gao; Xiaobin Shang; Lei Gong; Zhao Ma; Ke Sun; Peng Tang; Zhentao Yu
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

10.  Metastatic to negative lymph node ratio demonstrates significant prognostic value in patients with esophageal squamous cell carcinoma after esophagectomy.

Authors:  Xiao-Feng Duan; Peng Tang; Xiao-Bin Shang; Hong-Jing Jiang; Zhen-Tao Yu
Journal:  Oncotarget       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.